Literature DB >> 7096155

Effects of intracranial and left atrial hypertension on lung fluid balance in sheep.

T A Jones, M I Townsley, W J Weidner.   

Abstract

Elevation of intracranial pressure (ICP; 50-150 Torr) in sheep produces an increase in protein-rich lymph flow (QL) from the lung. This may be attributed to either microvascular permeability changes or increases in filtration surface area through recruitment. To eliminate increases in surface area, we recruited potential filtration beds by increasing left atrial pressure (Pla; 27-35 Torr) prior to elevating ICP in sheep anesthetized with pentobarbital sodium or halothane. Under these conditions, increased pulmonary microvascular permeability would be expected to produce an increased QL, lymphatic protein flux (CL), and plasma clearance of protein (CP). The results of ICP elevation following a period of steady-state Pla hypertension showed no such change in QL, CL or CP (n=8) compared with prior period of increased Pla. ICP elevation alone (n=6) produces a significant increase in CP manifested as an increase in QL (73%), with little change in the lymph-to-plasma ratio of protein concentration. These results suggest that a change in pulmonary microvascular surface area (not permeability) is the primary mechanism underlying increases in protein-rich QL following the elevation of ICP alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096155     DOI: 10.1152/jappl.1982.52.5.1324

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  2 in total

1.  Effects of sequential periods of intracranial hypertension on lung fluid balance.

Authors:  W J Weidner; T A Jones
Journal:  Experientia       Date:  1983-11-15

2.  Measurement of the filtration coefficient (Kfc) in the lung of Gallus domesticus and the effects of increased microvascular permeability.

Authors:  W Jeffrey Weidner; David S Waddell; J David Furlow
Journal:  J Comp Physiol B       Date:  2006-03-15       Impact factor: 2.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.